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Several  type C  RNA-transforming viruses  have been  shown  to contain  acquired 
cellular sequences within preexisting viral genes (I-3). In many instances expression 
of proteins encoded by such sequences occurs by inphase read through of translation 
initiated  at the 5' terminus of the viral genome.  Resulting polyprotein translational 
products  contain  type  C  viral  gag  gene  amino  terminal  structural  components 
covalently linked to acquired sequence-encoded components with probable transform- 
ing function (4-10). The nonstructural components of polyproteins encoded by several 
such virus isolates have been shown to resemble the well-characterized avian sarcoma 
virus-encoded transforming protein (11-13), pp60  src, in that they are highly phospho- 
rylated (14)  and exhibit associated protein kinase activity (14,  15) with specificity for 
tyrosine acceptor sites  (15-18).  Transformation by viruses of this group is associated 
with  elevated  levels  of total  cellular  phosphotyrosine  (17,  18)  and  a  reduction  of 
epidermal growth factor (EGF) a binding capacity (16,  19). 
Staa[ et al. (20)  have described the isolation of a weakly-transforming RNA type C 
virus from a  thymoma suspension culture developed from a  spontaneously lympho- 
matosis  AKR/J  mouse.  This  virus,  designated  T-8,  is  replication-defective  (20), 
transforms mink cells in vitro (20), and encodes, as its major translational product, a 
highly phosphorylated 110,000 mol wt polyprotein containing AKR-murine leukemia 
virus (MuLV) amino terminal gag gene components, p 15 and p 12 (21). The functional 
significance and role, if any, of this protein in transformation is, as yet, unknown.  In 
the present study, we have analyzed T-8 P 110 for possible acquired sequence encoded 
component(s)  and  have examined  levels of tyrosine-specific protein  kinase  activity 
and epidermal growth factor EGF binding by mink cell lines nonproductively infected 
by T-8. 
* Supported under Public Health Service contract N01-CO-75380 from the National Cancer Institute, 
Bethesda, Md. 
i Abbreviations used in  this paper: DME, Dulbeceo's modification of Eagle's medium; EGF, epidermal 
growth factor; MCF, mink cell focus forming; MuLV, murine leukemia virus; PBSTDS, 10 mM sodium 
phosphate, pH  7.2, 0.9% NaCI, 1.0% Triton  X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 
sulfate; SDS, sodium dodecyl sulfate; SDS-PAGE, SDS-polyacrylamide  gel electrophoresis; TPCK, tolyl- 
sulfonyl phenylalanyl chloromethyl ketone. 
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Materials  and  Methods 
Cells and Viruses.  Cell lines were maintained in Dulbecco's modification of Eagle's medium 
(DME)  supplemented with  10%  calf serum  (Colorado Serum  Co.,  Denver, Co.). Cells used 
included a  fetal mink lung cell line, CCL64, obtained from the American Culture Collection, 
Rockville, Md., and subclones of CCL64 nonproductively transformed by either T-8 virus (21) 
or AbLV (9) designated 64T8 and 64Ab-2, respectively. A Gardner FeSV transformed subclone 
of CCL64,  designated  64F3,  was  generously provided  by  G. J.  Todaro  (National  Cancer 
Institute, Bethesda, Md.). An Se-1 subclone productively infected with AKR-MuLV was also 
used. 
Immunoprecipitation, Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)  and 
Two-Dimensional T~yptic Peptide Analysis.  After labeling with [aSS]methionine (1075  Ci/mmol; 
Amersham Corp., Arlington Heights, Ill.) or [3H]lysine (78.1 Ci/mmol; New England Nuclear, 
Boston,  Mass.), cells were washed twice with serum-free DME  and  disrupted in lysis buffer 
containing  10 mM sodium phosphate, pH  7.2, 0.9%  NaCI,  1.0% Triton X-100, 0.5%  sodium 
deoxycholate, 0.1%  sodium dodecyl sulfate  (SDS)  (PBSTDS).  After clarification of lysates, 
virus-specific  proteins  were  immunoprecipitated  and  analyzed  by  SDS-PAGE  on  5-20% 
polyacrylamide gradient slab gels as described previously (22). [~S]methionine- and [3H]lysine- 
labeled proteins purified by immunoprecipitation and SDS-PAGE were digested by incubation 
with tolylsulfonyl phenylalanyl chloromethyl ketone (TPCK) trypsin (Worthington Biochemi- 
cal Corp., Freehold, N. J.), and two-dimensional analysis of the tryptic peptides was performed 
by electrophoresis for 30 rain at 500 V in electrophoresis buffer (acetic acid: formic acid: water, 
15:5:80)  and ascending chromatography in butanol, pyridine, acetic acid, and water (32:25:5: 
20). 
Competition Immunoassays.  Unlabeled antigens were assayed at serial twofold dilutions for the 
ability to compete with 12SI-labeled AKR-MuLV p|5 or p 12 for binding limiting amounts of 
goat  anti-serum directed against detergent-disrupted AKR-MuLV.  Reaction  mixtures con- 
tained  0.01  M  Tris-HCI,  pH  7.8,  1.0  mM  EDTA,  0.4%  Triton  X-100,  1%  bovine  serum 
albumin, and 0.05 M  NaC1 in a total vol of 0.2 ml. In assays in which AKR-MuLV pl5 was 
used as the 12SI-labeled antigen, the NaCI concentration was increased to 0.2 M. Antiserum and 
unlabeled competing antigen were  incubated at  37°C  for  1 h,  followed by the  addition of 
10,000  cpm  l~I-labeled antigen. After further incubation, antigen-antibody complexes were 
immunoprecipitated, and radioactivity quantitated as previously described (22). 
Assay  for Protein Kinase Activity.  Phosphorylation of proteins in an in vitro phosphotransferase 
reaction was performed as described by Blomberg et al. (16).  Briefly, tissue culture cells (107) 
were disrupted by repeated aspiration through a  25-gauge needle in 5 ml of 10 mM sodium 
phosphate, pH 7.2, buffer containing 100 mM NaCI, 5 mM MgCI2,  1 mM EDTA, and  1.0% 
Triton X-100, and clarified by centrifugation at 2000 g for 10 min. Supernates were preabsorbed 
by addition of normal goat serum (50/~1) and 0.5 ml of a  10% suspension of protein-A Sepharose 
CI-4B  (Pharmacia  Fine Chemicals,  Div.  of Pharmacia  Inc.,  Piscataway,  N. J.),  incubated 
overnight at 4°C,  and reclarified by centrifugation at  100,000  g  for 2 h.  Viral proteins were 
immunoprecipitated by  incubation  with  antiserum  and  protein-A Sepharose as previously 
described (16).  Immunocomptexes were collected by centrifugation for  10 min at 2000 g and 
washed in PBSTDS buffer. Protein kinase activity was assayed by resuspension of immunopre- 
cipitates in 20 mM Tris-HCl, pH 7.2, 5 mM MgCI2 buffer containing 1 pCi [y3zp]ATP (2,000 
Ci/mM;  New  England  Nuclear)  and  incubation of reaction mixtures  for  10  min  at  30°C. 
Reactions were terminated  •  32  by addition of 3 ml ice cold PBSTDS, nonprotein bound  P-label 
was  removed by repeated centrifugation in  excess PBSTDS,  and  a2P-labeled proteins were 
analyzed by SDS-PAGE. 
Phosphoamino Acid  Separation.  a2P-labeled  proteins  contained  in  protein  kinase  reaction 
mixtures were purified by SDS-PAGE, and selected gel slices heated at  110°C  for  1 h  in 200 
pl of 6 N hydrochloric acid. Hydrolyzed samples were filtered, lyophilized, resuspended in 1 ml 
deionized water,  lyophilized a  second  time, and  dissolved in  buffer containing acetic acid: 
formic acid: water (15:5:80), pH  1.9. Phosphoamino acid standards including o-phospho-n- 
serine and o-phospho-oL-threonine were purchased from Sigma Chemical Co., St. Louis, Mo. 
o-Phospho-L-tyrosine  was synthesized as previously described (17). Hydrolyzed samples (3,000- 
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cm cellulose thin-layer chromatography plates. Two dimensional separation was performed by 
electrophoresis  for 1 h in acetic acid: formic acid:  water (15:5:80) buffer and chromatography 
in  the second  dimension  in  0.5  M  ammonium hydroxide:  isobutyric acid  (3:5). Unlabeled 
phosphoamino acid standards were detected by the ninhydrin reaction, and 32p-labeled amino 
acids visualized  by autoradiography on X-Omat R  film with  the use  of calcium tungstate 
intensifying screens (Eastman Kodak Co., Rochester, N. Y.). 
Epidermal Growth Factor Binding.  Cells were plated in  24 well cluster plates (Costar,  Data 
Packaging, Cambridge, Mass.) at ~ 105 cells/well.  48 h later, individual wells were washed once 
with DME containing 10% calf serum, incubated for 3 h at 37°C in serum-free DME, and for 
an additional 4 h at 4°C in 0.2 ml of Hepes-buffered (pH 7.4) DME containing 0.1% ovalbumin 
and  1.0-20  ng/ml mouse EGF (Collaborative Research, Inc., Waltham, Mass.)  labeled with 
~2sI at  a  specific  activity of 20-30 pCi/pg  by  the  chloramine  T  method  (23). Cells  were 
subsequently  washed  three  times  in  serum-free  DME,  dissolved  in  1%  SDS  (1  ml),  and 
radioactivity was measured in a gamma scintillation counter. Cell numbers were determined 
by staining with  Sedi-stain  (Becton-Dickinson  & Co.,  Ltd.,  Drogheda,  Ireland)  and  visual 
enumeration of three randomly chosen 0.03-ram  2 fields in each of six wells/cluster plate. 
Results 
Characterization of T-8  P110 by Immunoprecipitation and SDS-PAGE Analysis.  Initial 
characterization  of T-8 P110  was accomplished by immunoprecipitation and  SDS- 
PAGE analysis. As shown  in Fig.  1, T-8 P110  and a  second protein of ~55,000  Mr 
were  immunoprecipitated  from the  64T8  mink cell  line  by anti-Rauscher  MuLV, 
anti-Rauscher-MuLV  p12,  and  to  a  lesser  extent,  by  anti-Rauscher-MuLV  p30. 
Neither  P110  nor  P55  were  immunoprecipitable  by a  high  titered  anti-Rauscher- 
MuLV pl0 serum.  Because the anti-Rauscher-MuLV p30 serum used in this study 
has  been  shown  to  contain  low  level  anti-pl2  reactivity  (24),  this  result  does  not 
necessarily indicate the presence of p30 determinants in P 110. In contrast to sera with 
specificity  for  Rauscher-MuLV  gag  gene  components,  a  previously-described  (24) 
high-titered anti-Rauscher-MuLV gp70 serum precipitated AKR-MuLV Pr82  e"v and 
gp70 from AKR-MuLV-infected cells, but did not precipitate the  110,000 or 55,000 
Mr T-8 encoded polyproteins to a significant extent. In other studies, we have found 
both P110 and P55 to be precipitated by anti-Rauscher-MuLV p15 but not by anti- 
AKR-MuLV pl5(E)  (data not shown). The absence of detectable levels of either P110 
or P55  expression in uninfected  control mink cells argues for the viral specificity of 
both proteins. 
Identification of [asS]Methionine-labeled  T~yptic Peptides Unique to T-8 P1 I0.  The above 
findings raise the possibility that P110  may consist of AKR-MuLV amino terminal 
gag  gene  structural  (P15  and  p12)  components  covalently  linked  to  an  acquired 
sequence-encoded nonstructural  component. Alternatively, on the basis of molecular 
weight  and  antigenic  criteria,  the  possibility  that  T-8  Pll0  might  represent  the 
translation  product  of an  inphase deletion  of the middle third  of the AKR-MuLV 
gag/pol  gene  must  be considered.  In  an  effort  to  resolve  these  alternative  models, 
[~S]methionine-labeled T-8 P110 and AKR-MuLV translational products, including 
Prl80  e°~/p°l, Pr65  g'~, p30,  and  Pr82 end, were purified  by immunoprecipitation  and 
SDS-PAGE (Fig.  1A and F), and subjected to tryptic peptide analysis. As shown in 
Fig. 2A, AKR-MuLV Prl80  g'~/p°t contained twelve major well-resolved [aSS]methio- 
nine-labeled peptides.  In contrast,  in the case of Pr65  gag (Fig.  2 B)  only two labeled 
peptides were seen, both of which were specific to its p30 component (Fig. 2 C). In a 
mixing experiment, these are shown to correspond to two of the PrlSO  g°~/p°t peptides 
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Fro.  1.  Immunoprecipitation and SDS-PAGE analysis of proteins encoded by AKR-MuLV and 
the T-8 virus isolates. Cell lines including AKR-MuLV-infected  Sc-1 mouse cells (A-D), 64T8 (E- 
I), and control (J) CCL64 mink cells were pulse-labeled in [~S]methionine (100 #Ci/ml) containing 
medium  for 30 rain,  immunoprecipitated with either goat  antiserum  directed against  detergent 
disrupted Rauscher-MuLV  (A, E, J), antisera with  specificity for Rauscher-MuLV  p30  (B, G), 
Rauscher-MuLV  p12 (F), Rauseher-MuLV  pl0 (H), and Rauscher-MuLV  gp70 (C, I), or control 
goat  serum  (D), and analyzed by SDS-PAGE.  Molecular  weight standards include  I+C-labeled 
phosphorylase B (98,000), bovine serum albumin (69,000), ovalbumin  (46,000), carbonic anhydrase 
(30,000), and cytochrome c (12,000). 
composition,  a  second  AKR-MuLV  gag  gene  component,  p12,  has  been  shown  to 
contain a  methionine residue (25), for reasons which are not apparent, we were unable 
to identify a  [~S]-methionine labeled tryptic peptide unique to p12. 
Analysis of T-8  P110,  under  similar  conditions,  revealed  a  total  of seven  well- 
resolved  methionine-containing  peptides  (Fig.  3A).  In  an  effort  to  rule  out  the 
possibility that one or more of the labeled peptides observed might actually consist of 
multiple peptides migrating at identical positions, digests were analyzed using differ- 
ent separation conditions (Fig. 3 B and C). In each case, a  total of seven peptides were 
observed. Of these, two peptides, 4 and 5, which showed some overlap in the original 
separation  shown  in  Fig.  2,  panel  A,  were  clearly  resolved.  To  determine  the 
representation  of Pr65  g°~  components  in  T-8  P110,  a  mixing experiment  was  per- 
formed. As shown in Fig. 4, one of the two p30-specific peptides was clearly separated 
from  all seven  T-8  P110  peptides, whereas  the  second  p30  peptide,  designated  (a), 1766  IDENTIFICATION OF TRYPTIC  PEPTIDES 
Fro.  2.  [aSS]methionine tryptic peptide compositions ofAKR-MuLV Prl80  s~/~/(A), Pr65  ~'~ (B), 
p30 (C), and identification of tryptic peptides shared by AKR-MuLV Prl80  g'~/°°t and Pr65  ~°~ (D). 
86  ag/pol  [  S]methionine-labeled Prl80  g  ,  Pr65  e'~ and p30  were  isolated  from  Sc-1 cells productively 
infected with AKR-MuLV by immunoprecipitation  and SDS-PAGE as described in Fig. 1. Proteins 
were digested with TPCK trypsin as described  in Materials and Methods.  Tryptic digests (4,000- 
12,000 cpm) were resuspended  in electrophoresis buffer, spotted on cellulose thin layer glass plates 
(O), and separated  in two dimensions  by electrophoresis and ascending chromatography. The twelve 
85  og/pol  major [  S]methionine-labeled  peptides represented  in AKR-MuLV Prl80  ¢  are labeled a-l. 
partially overlapped with  P110  peptide 6.  These findings establish that  at  least one, 
and  probably both, of the AKR-MuLV  Pr65  g°~ methionine-containing tryptic pep- 
tides are unique to Pr65  g~g and not represented within T-8 P 110. 
To extend the above findings and test whether P110 might contain specific peptides 
not of Prl80  g°~/~l origin, [aSS]methionine-labeled tryptic peptides of the two proteins 
were analyzed in a  mixing experiment. For this purpose, the separation conditions in 
Fig.  3C  were  used.  As  shown  in  Fig.  5A,  the  twelve  AKR-MuLV  Prl80  g~/p°t 
methionine-containing tryptic peptides were well-resolved under these conditions, and 
the overall  tryptic  map  was  distinct  from  that  exhibited  by T-8 P110.  In a  mixing 
Fro:  3.  Identification of [aSS]methionine-labeled tryptic peptides  in T-8 PII0.  [aSS]methionine- 
labeled T-8 P1 I0 was purified by immunoprecipitation and SDS-PAGE, and subjected to tryptic 
peptide analysis  as described  in Fig. 2. Separation of the tryptic peptides  by electrophoresis  was 
performed  as described  in Materials and Methods,  and ascending chromatography was in buffer 
containing butanol, pyridine, acetic  acid, and water  (32:25:5:20)  (A), butanol, acetic  acid,  and 
water (80:20:20) (B), or ethanol and water (70:30) (C). Individual tryptic peptides are labeled 1-7. 1767 1768  IDENTIFICATION OF TRYPTIC PEPTIDES 
FIG. 4.  Comparison of T-8 P110 and AKR-MuLV Pr65  g~ [~S]methionine-labeled tryptic pep- 
tides. [3~S]methionine-labeled proteins including T-8 P110 and AKR-MuLV Pr65  g~ were purified 
as described in Fig. 1, mixed at 1:1 ratio, and subjected to tryptic peptide analysis as described in 
the  legend to Fig. 2.  Individual  peptides of AKR-MuLV Pr65  g"g and  T-8  PII0 are labeled as 
described in Figs. 2 and 3, respectively. 
experiment,  at  least  four of the  seven  methionine-containing  P110  tryptic  peptides 
are  shown  to be completely separable  from peptides  derived  from  Prl80  gag/p°l (Fig. 
5 B). The migration patterns of the three remaining P 110 peptides and their relation- 
ship  to  Prl80  gag/p°t peptides  are  inconclusive.  These  findings  are  summarized  sche- 
matically in Fig. 5 C. 
Demonstration  of  Structural  Components  Common  to  AKR-MuLV  Pr65  g°g  and  T-8 
PIIO.  The  lack  of conclusive  evidence  for methionine-containing  tryptic  peptides 
common to  Prl80  gag/~l and  T-8  P110  raised  the  possibility  that  T-8  P110  may be 
completely unrelated  to AKR-MuLV.  To examine  this possibility,  the p15  and  p12 
reactivities  associated  with  Pll0  were  analyzed  with  respect  to  immunologic  type 
specificity. As shown in Fig. 6A, in a  competition immunoassay in which anti-AKR- 
MuLV was used for precipitation of lz~I-labeled AKR-MuLV p 15, an extract prepared 
from mink cells nonproductively-infected with T-8 competed to the same final extent 
as detergent disrupted sucrose density gradient-purified AKR-MuLV. In contrast, an 
extract  of uninfected control mink cells did not compete to significant  extent  in this 
assay.  Of other  virus  isolates  tested,  mouse  mammary  tumor  virus  was completely 
nonreactive,  whereas  Moloney-MuLV  competed  to  final  extent  of ~25%.  Similar 
findings were obtained upon analysis of the p12 type specificity ofT-8 P110. As with 
p15,  the  pattern  of competition  of T-8  Pll0  was  distinct  from  that  of Moloney- 
MuLV, but indistinguishable  from AKR-MuLV. These findings thus provide strong 
immunologic evidence for the AKR-MuLV  specificity of the T-8 P110 p15 and p12 
structural components. 
As  an  independent  approach  to  establish  the  relatedness  of T-8  Pll0  to  AKR- 
MuLV  Prl80  g°~/p°t, tryptic  peptide  analysis  was performed  following labeling  with 
[3H]lysine. The results indicate ~33 and 27 labeled peptides in Pr65  g°g (Fig.  7 A) and 35  ag/pol  Fia.  5.  Comparison of [  S]methionine tryptic peptide compositions of AKR-MuLV Prl80  g 
and T-8 P110.  [  S]methionine-[abeled AKR-MuLV Prl80  g  and T-8 PI[0 were isolated and 
subjected to tryptic peptide digestion as described in the legend to Fig. 2. Electrophoretic separation 
of tryptic  peptides  was  in  buffer containing acetic  acid,  formic  acid,  and  water  (15:5:80),  and 
ascending chromatography was in ethanol and water (70:30). Proteins tested included AKR-MuLV 
ag/pol  ag/pol  Pr18(f  (A), and a  1:1 mixture ofAKR-MuLV Pr180  g  and T-8 P110 (B). Panel C represents 
a  schematic drawing of the tryptic  peptide  migration  patterns of a  l:l  mixture of AKR-MuLV 
Prl80  g~/ml (0)  and T-8 P110 (C)). Peptides presented in tryptic maps of the two proteins and not 
resolved by the separation conditions used are indicated as (O). 
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FIG.  6.  Homologous competition immunoassays for AKR-MuLV pl5 (A) and p12 (B). Virus and 
cell extracts prepared as described in the text were tested at serial twofold dilutions for ability to 
compete with ]2SI-labeled AKR-MuLV  p15 or p12  for binding limited amounts of antibody to 
detergent-disrupted AKR-MuLV.  Results are expressed as mean values of two separate determi- 
nations, and are normalized to  100% maximal binding at infinite antigen dilution. Viruses were 
tested at an initial concentration of 100/xg/ml and included AKR-MuLV  (O),  Moloney-MuLV 
(A), and mouse mammary tumor virus ('). Cell extracts were tested at initial dilutions of 1 mg/ml 
and included 64"£8 (O) and CCL64 control mink cells (A). 
P 110 (Fig.  7 B), respectively.  Moreover,  in a  mixing experiment  (Fig.  7 D)  ~6  of these 
peptides  are  seen  to  overlap,  whereas  the  remaining  27  Pr65  gag  and  21  T-8  P1 I0 
peptides  are specific  to  their respective  genomes.  These  findings  are  consistent  with 
previous  estimates  of  33  lysine  residues  in  AKR-MuLV  Pr65  gag,  8  of  which  are 
localized  in  its p15  and  p12  components.  Upon  similar analysis,  Pr82  e"v is shown  to 
contain ~26 well-resolved lysine-containing tryptic peptides, none of which correspond 
to  those  derived  from  either  Pr65  gag or  P110.  The  lack  of representation  of Pr82 e"v 1771 
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FtG. 8.  Analysis of protein kinase activities associated with high molecular weight viral polypro- 
reins  in  mink cells nonproductively  infected with AbLV, Gardner FeSV, and T-8.  Cells were 
disrupted, immunoprecipitated,  assayed for [73ZP]ATP phosphotransferase activity, and analyzed 
by SDS-PAGE as described in Materials and Methods. Cell lines tested included  AbLV (A, B), 
Gardner FeSV  (E, F), and T-8  (C, D)  nonproductively-infected  and uninfected  control  (G, H) 
CCL64 mink cells. Sera used included goat anti-Moloney  MuLV (A, C, G), goat anti-FeSV P115 
(E), and normal goat serum (B, D, F, H). 
peptides in either Pr65  g~ or T-8 P110 was confirmed by appropriate mixing experi- 
ments  (data not shown). 
Analysis of T-8 P1 l O  for Associated Protein Kinase Activity.  High molecular polyprotein 
translational  products  of mammalian  transforming  viruses such  as  AbLV  and  the 
Gardner  strain  of FeSV  are  highly  phosphorylated  and  exhibit  associated protein 
kinase  activities with  specificity for  tyrosine acceptor sites.  In  view of our  previous 
results establishing T-8 P 110  to be phosphorylated, it was thus of interest to analyze 
it for protein kinase activity. For this purpose, T-8 P110 was analyzed for autophos- 
phorylation under in vitro conditions in the presence of [BazP]ATP. As shown in Fig. 
8, in contrast to AbLV P120, AbLV P80, Gardner FeSV P115, and a  normal  150,000 FIG.  9.  Identification of amino acid acceptor residues phosphorylated in an in vitro phosphotrans- 
ferase reaction.  Proteins were ~P-labeled,  hydrolyzed, and subjected to  two-dimensional analysis 
according to procedures described in Materials and Methods. Phosphoamino acid standards include 
phosphoserine (p-ser), phosphothreonine (p-thr), and phosphotyrosine (p-tyr).  Equimolar concen- 
trations of all three standards were mixed with a 32p-labeled hydrolysate of CCL64 mink cells (A), 
AbLV-transformed CCL64 mink cells (B), and T-8-transformed CCL64 mink cells (C). Positions of 
phosphoamino acids were visualized by both ninbydrin reaction and autoradiography. 
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FIG,  10.  Comparison of EGF binding by AbLV (O), Gardner FeSV (~), and T-8 (C)) nonproduc- 
tively-infected and uninfected control (D) CCL64 mink cells. Results are presented as mean values 
of triplicate binding determinations corrected for nonspecific adsorption by subtraction of the values 
from wells containing an additional 100 ng of unlabeled EGF as competitive inhibitor. This activity 
corresponded to  0.3-0.7  pg/well.  Standard  deviation  values  represent  the  sum  of deviation  of 
binding determinations and cell counts. 
Mr mink cellular protein, which were efficiently labeled using these conditions, T-8 
P110 was not detectably labeled. 
In addition to the demonstration of tyrosine-specific protein kinase associated with 
AbLV and Gardner FeSV encoded polyproteins, cells transformed by these viruses 
have been shown to exhibit elevated levels of phosphotyrosine (15-18). It was thus of 
interest  to analyze T-8 nonproductively-infected CCL64 mink ceils with respect to 
total phosphoamino acid composition. As shown in Fig. 9, in addition to phosphoserine 
and phosphothreonine, AbLV nonproductive transformed mink cells exhibit readily 
detectable levels of phosphotyrosine. In contrast, by the procedures used in the present 
study,  the levels of phosphotyrosine in uninfected or T-8 nonproductively infected 
mink cells were below detectability. 
EGF  Binding  by  T-8-infected  Mink  Cells.  There  is  accumulating  evidence  for  a 
decrease in  EGF binding  by type C  viral  transformed, as compared to uninfected 
control mink cells (19,  26).  Moreover, in the case of AbLV transformation, there is 
evidence for a  close association  between  cellular levels of tyrosine specific protein 
kinase activity and EGF binding (16).  Tocxplore the possible influence of T-8 P110 
expression  on  EGF  binding,  T-8  nonproductively-infected and  control  uninfected 
mink cells were analyzed for binding of 125I-labeled  EGF. As a  positive control for 
transformation-associated loss of EGF binding, AbLV and Gardner FeSV transformed 
mink cells were similarly analyzed. As shown in Fig.  10, binding of l~SI-labeled  EGF 
by AbLV and  Gardner FeSV transformed cells was  much lower than  the levels of 
binding  exhibited  by  uninfected  control  mink  cells.  In  contrast,  binding  by  T-8 
nonproductively-infected and control mink cells did not differ significantly. 
Discussion 
The spontaneous development of thymic tumors in high leukemia incidence strains 
of mice is etiologically associated with activation of endogenous ecotropic MuLV (27). 
The isolation, from preleukemic and leukemic thymus tissues, of MuLV variants with VAN DE VEN, REYNOLDS, JR., BLOMBERG, AND STEPHENSON  1775 
altered host range (28, 29) and recombinant env genes (30, 31) has raised the possibility 
that alterations within env may be involved in tumor induction. This is supported by 
the ability of such isolates, designated as mink cell focus forming (MCF)  viruses, to 
induce morphologic alteration of mink cells in tissue culture (29). The more recent 
isolation of transforming variants from thymus cell-derived MCF virus stocks, one of 
which  has been shown  to be replication-defective (20)  and to encode, as its major 
translation product, a  1 I0,000 Mr polyprotein (21), suggested a  model analogous to 
that described for other mammalian RNA transforming viruses such as avian acute 
leukemia virus (4,  7,  10), several independent isolates of FeSV (5, 6), and AbLV (8, 
9). 
In  the present  study, we have further characterized the  110,000 Mr polyprotein 
encoded by the T-8 isolate of MuLV (21). This highly phosphorylated viral-encoded 
protein is shown to contain amino terminal gag gene structural components but  to 
lack immunologic cross-reactivity with other known AKR-MuLV translational prod- 
ucts. The possibility that T-8 P110 may contain a minor portion of p30 and thus the 
p12-p30  posttranslational  cleavage  site,  cannot  be  excluded.  However  one,  and 
probably both, of the AKR-MuLV p30 methionine-containing tryptic peptides are 
absent from T-8 P110. These findings, in combination with the demonstration of at 
least four well-resolved methionine-containing tryptic peptides unique to T-8 P110, 
are consistent with the possibility that all but the amino terminal portion of P110 is 
encoded by acquired sequences. These presumably are inserted at an inphase position 
within the gag/pol region of the AKR-MuLV genome. In this respect, the T-8 P110 
polyprotein  appears  to  resemble  high  molecular  weight  polyprotein  translational 
products encoded by avian acute Leukemia viruses, AbLV and various FeSV isolates. 
The lack of detectable gp70  or pl5(E)  expression in  T-8 nonproductively-infected 
cells  could  be  explained  on  the  basis  of such  an  insertion  extending  into  the  5' 
terminus of the AKR-MuLV env gene. 
An alternative, although less likely explanation of the present findings, is that T-8 
P110 represents the translational product of a partially-deleted AKR-MuLV gag/pol 
gene. Such a deletion would presumably be inphase and extend from the 3' terminus 
of sequences encoding p 12 to the middle of the pol gene. The identification of at least 
four methionine-containing tryptic peptides unique to T-8 P110 could be accounted 
for on the basis of the location of such peptides adjacent to deletion sites, or reflect 
major differences in  posttranslational  modification of T-8  P110  and  AKR-MuLV 
PrlSO  g'g/p°t.  Implicit  within  such  a  model  is  the  additional  speculation  that  the 
deleted gag/pol gene product acquires transforming capacity as a consequence of an 
inphase deletion, or that  an as yet unidentified T-8 gene product is responsible for 
transformation. 
Although the T-8 nonproductively-infected mink cell line used in the present study 
was  initially derived based on a  capacity for growth  in soft agar  (20), the cells no 
longer exhibit this property nor appear morphologically-transformed. Moreover, T-8 
P110 lacked detectable protein kinase activity, and T-8-infected mink cells exhibited 
neither  the  elevated  levels of phosphotyrosine kinase  (15,  17,  18,  32)  activity nor 
reduction of EGF binding sites  (16,  19) characteristic of cells transformed by avian 
sarcoma virus or by mammalian type C  viruses such as AbLV and the Gardner and 
Snyder-Theilen strains of FeSV. Thus, as one possibility, transformation by T-8 may 
involve different  mechanisms  than  transformation  by other  RNA  type C  viruses. 1776  IDENTIFICATION OF TRYPTIC  PEPTIDES 
Alternatively,  morphologic  reversion  of T-8  transformation  subsequent  to  initial 
isolation of the 64T8  cell  line  may have been associated with  loss of P110  protein 
kinase activity and restoration of EGF binding sites. In this respect it should be noted 
that transformation of mink cells by other RNA-transforming viruses such as AbLV 
(17,  33)  and FeSV (34, 35)  often reverts at high frequency and is associated with loss 
of polyprotein  expressio,  n.  In  addition,  transformation-defective  mutants  of AbLV 
have been described that express AbLV P120 at levels comparable to wild type AbLV 
transformants but  lack tyrosine specific protein  kinase  activity  (17).  Elucidation  of 
molecular events  involved in  loss of T-8 associated  phenotypic  transformation will 
require  further  study.  By  this  means,  it  may  be  possible  to  gain  insight  into  the 
functional significance of T-8 P 110 and determine the role, if any, of its nonstructural 
component in T-8 transformation. 
Summary 
Mink cells nonproductively-infected with  the  weakly-transforming T-8 isolate of 
murine leukemia Virus(MuLV)  express a  110,000 mol wt polyprotein designated T- 
8 P 110. By immunoprecipitation analysis, T-8 P 110 is shown to contain AKR-MuLV 
amino terminal gag gene-specific components (p15, p12)  but to lack p30, pl0, gp70, 
and p15(E)  antigenic determinants.  These observations are further substantiated  by 
tryptic peptide analysis indicating T-8 P110  to share approximately six lysine-con- 
taining  tryptic  peptides  with  AKR-MuLV  Pr65  g'~,  and  none  with  AKR-MuLV 
Pr82 e"~. Furthermore, of seven methionine-containing T-8 P110  tryptic peptides, at 
least  four  can  be  conclusively  shown  not  to  be  present  in  either  AKR-MuLV 
PrlS0  g°~/~t or Pr82 e"~. A clonal mink cell line nonproductively infected by T-8, and 
expressing high levels of P110,  although  not morphologically transformed, is shown 
to  lack elevated  levels of tyrosine-specific protein  kinase  activity  and  reduction  of 
epidermal  growth  factor binding  sites characteristic  of cells  transformed  by many 
other  RNA-transforming  viruses.  These  findings  argue  either  that  the  T-8  viral 
genome contains acquired cellular sequences encoding a portion of P110, or that T-8 
Pll0  represents  an  inphase  deletion  of AKR-MuLV  Prl80  go~/~t  with  extensive 
posttranslational  modification and that an as yet unidentified  protein is responsible 
for T-8 associated transformation. 
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